Ontology highlight
ABSTRACT: CDK4/6 inhibition sensitizes myeloma to lenalidomide by reducing the MEIS2 to CRBN ratio that accelerates IKZF1 and IKZF3 degradation
PROVIDER: PRJNA307260 | ENA |
REPOSITORIES: ENA
ACCESS DATA
